Injectable Drug Delivery Market by Type (Device, Formulation), Therapeutic (Cancer), Usage Pattern (Immunization), Administration (Skin, Musculoskeletal), Distribution Channel (Hospital), Patient Care Setting (Hospital, Home Care) - Forecast to 2021

注射可能薬剤送達の世界市場予測(~2021年)

◆タイトル:Injectable Drug Delivery Market by Type (Device, Formulation), Therapeutic (Cancer), Usage Pattern (Immunization), Administration (Skin, Musculoskeletal), Distribution Channel (Hospital), Patient Care Setting (Hospital, Home Care) - Forecast to 2021
◆商品コード:MAM-MD-3680
◆調査・発行会社:MarketsandMarkets
◆発行日:2017年2月6日
◆ページ数:258
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single User(1名利用)USD5,650 ⇒換算¥627,150見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥738,150見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥904,650見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

当調査レポートでは、注射可能薬剤送達の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、種類別分析、治療分野別分析、投与経路別分析、流通チャネル別分析、注射可能薬剤送達の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

The global injectable drug delivery market, in terms of value, is projected to reach USD 624.50 billion by 2021 from USD 362.38 billion in 2016, at a CAGR of 11.5% during the forecast period.
The increase in the use of biologics, the increase in the prevalence of chronic diseases, the increasing occurrence of needlestick injuries, and the benefits of injections (convenience, ease of use, and reduced pain) have driven the growth of the injectable drug delivery market. These factors have increased the demand for devices such as safety syringes, prefilled syringes, and autoinjectors. However, the growing use of alternative delivery methods, safety concerns, and risk of transmission of blood-borne infections may hinder the growth of the market.

The injectable drug delivery is segmented based on type, formulation packaging, therapeutic application, usage pattern, site of administration, distribution channel, facility of use, and regions. Injectable drug delivery market by distribution channel is further segmented into hospitals and pharma stores. Hospitals are expected to account for a large share in this market, as hospitals provide injectables for the inpatients as well as to the outpatients, owing to which there is maximum sale of injectable formulations and devices through the hospitals. In addition, it provides pharmacy care for inpatients as well as patients from other clinics, ambulatory centers, patients discharged from healthcare facilities, and those receiving home care.

The Injectable drug delivery market by facility of use is segmented into hospitals and clinics, home care settings, and other facilities of use. The hospitals and clinics segment is expected to account for the largest share of the market, primarily due to the rising incidence of chronic diseases such as diabetes and cancer which require a large number of injectables for their treatment.

Asia is expected to be the fastest growing region in the market from 2016 to 2021 due to the rising incidence of chronic and autoimmune diseases, the rising aging population, and the high penetration of self-injection techniques & technologies in countries such as China, Japan, and India.
Prominent players in the injectable drug delivery market include Becton, Dickinson and Company (U.S.), Baxter International (U.S.), Pfizer (U.S.), Gerresheimer AG (Germany), Schott AG (Germany), Eli Lilly and Company (U.S.), and Terumo Corporation (Japan).

Research Coverage:
The report defines, describes, and forecasts the injectable drug delivery market on the basis of type, formulation packaging, therapeutic application, usage pattern, site of administration, distribution channel, and facility of use. It provides detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, challenges). The study tracks and analyzes competitive developments such as joint ventures, mergers & acquisitions, product developments, and expansions in the injectable drug delivery market across four main regions, namely, North America, Asia, Europe, and the Rest of the World (RoW).

Reasons to buy the report:
The report provides clients market size information on various segments of the injectable drug delivery market. This report also provides access to the quantitative data on the market. This report covers –
• Current and forecast assessment of the injectable drug delivery market
• Country-wise assessment of each of the segments
• Global market share analysis for major segments of the injectable drug delivery market
• Adoption Trends of injectable drug delivery for major geographic markets
• Five-year coverage of strategic developments of top players in the injectable drug delivery market
• Product Portfolio mapping of leading players in the injectable drug delivery market

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION 24
1.1 OBJECTIVES OF THE STUDY 24
1.2 MARKET DEFINITION 24
1.3 MARKET SCOPE 25
1.3.1 MARKETS COVERED 25
1.3.2 YEARS CONSIDERED FOR THE STUDY 26
1.4 CURRENCY 26
1.5 LIMITATIONS 26
1.6 STAKEHOLDERS 26

2 RESEARCH METHODOLOGY 27
2.1 MARKET SIZE ESTIMATION 28
2.2 MARKET BREAKDOWN AND DATA TRIANGULATION 30
2.3 KEY DATA FROM SECONDARY SOURCES 32
2.4 KEY DATA FROM PRIMARY SOURCES 33
2.5 ASSUMPTIONS FOR THE STUDY 33

3 EXECUTIVE SUMMARY 34

4 PREMIUM INSIGHTS 37
4.1 INJECTABLE DRUG DELIVERY: MARKET OVERVIEW 37
4.2 INJECTABLE DRUG DELIVERY MARKET, BY FACILITY OF USE 37
4.3 GEOGRAPHIC ANALYSIS: INJECTABLE DRUG DELIVERY MARKET, BY SITE OF ADMINISTRATION 38
4.4 INJECTABLE DRUG DELIVERY MARKET, BY FORMULATION PACKAGING 38
4.5 GEOGRAPHICAL SNAPSHOT: INJECTABLE DRUG DELIVERY MARKET 39

5 MARKET OVERVIEW 40
5.1 INTRODUCTION 41
5.2 MARKET DYNAMICS 41
5.2.1 DRIVERS 42
5.2.1.1 Rising prevalence of chronic diseases 42
5.2.1.2 Increase in demand for self-injection devices 42
5.2.1.3 Growth in the biologics market 43
5.2.1.4 Technological advancements and new product launches 43
5.2.2 RESTRAINTS 44
5.2.2.1 Infections associated with needlestick injuries 44
5.2.2.2 Product recalls 45
5.2.3 OPPORTUNITIES 45
5.2.3.1 Increase in demand for biosimilar and generic injectables 45
5.2.3.1.1 Biosimilars 45
5.2.3.1.2 Generic injectables 46
5.2.3.2 Contraceptive injectables 47
5.2.4 CHALLENGE 48
5.2.4.1 Preference for other modes of drug delivery 48

6 REGULATORY SCENARIO 49
6.1 INTRODUCTION 49
6.2 FDA AND CE APPROVALS 49
6.3 THE EUROPEAN MEDICINES AGENCY (EMA) 50
6.4 CLINICAL TRIALS 50

7 INJECTABLE DRUG DELIVERY MARKET, BY TYPE 51
7.1 INTRODUCTION 52
7.2 DEVICES 52
7.2.1 CONVENTIONAL INJECTION DEVICES 53
7.2.1.1 By Material 54
7.2.1.1.1 Glass 55
7.2.1.1.2 Plastic 56
7.2.1.2 By Product 57
7.2.1.2.1 Fillable syringes 57
7.2.1.2.2 Prefilled syringes 58
7.2.1.3 By Usability 59
7.2.1.3.1 Reusable injection devices 59
7.2.1.3.2 Disposable injection devices 60
7.2.2 SELF-INJECTION DEVICES 61
7.2.2.1 Needle-free Injectors 62
7.2.2.1.1 By product 63
7.2.2.1.1.1 Fillable needle-free injectors 63
7.2.2.1.1.2 Prefilled needle-free injectors 64
7.2.2.1.2 By technology 65
7.2.2.1.2.1 Jet-based needle-free injectors 65
7.2.2.1.2.2 Spring-based needle-free injectors 66
7.2.2.1.2.3 Laser-powered needle-free injectors 67
7.2.2.1.2.4 Vibration-based needle-free injectors 68
7.2.2.1.3 By usability 68
7.2.2.1.3.1 Reusable needle-free injectors 69
7.2.2.1.3.2 Disposable needle-free injectors 69
7.2.2.2 Autoinjectors 70
7.2.2.2.1 By Product 71
7.2.2.2.1.1 Fillable autoinjectors 71
7.2.2.2.1.2 Prefilled autoinjectors 72
7.2.2.2.2 By Technology 72
7.2.2.2.2.1 Automated autoinjectors 73
7.2.2.2.2.2 Manual autoinjectors 73
7.2.2.2.3 By Design 74
7.2.2.2.3.1 Standardized autoinjectors 74
7.2.2.2.3.2 Customized autoinjectors 75
7.2.2.2.4 By Usability 76
7.2.2.2.4.1 Reusable autoinjectors 76
7.2.2.2.4.2 Disposable autoinjectors 77
7.2.2.3 Pen injectors 77
7.2.2.3.1 By Product 78
7.2.2.3.1.1 Single-chambered pen injectors 79
7.2.2.3.1.2 Dual-chambered pen injectors 79
7.2.2.3.2 By Design 80
7.2.2.3.2.1 Standard pen injectors 81
7.2.2.3.2.2 Customized pen injectors 81
7.2.2.3.3 By Usability 82
7.2.2.3.3.1 Reusable pen injectors 82
7.2.2.3.3.2 Disposable pen injectors 83
7.2.2.4 Wearable injectors 83
7.2.2.5 Other Devices 84
7.3 FORMULATIONS 85
7.3.1 CONVENTIONAL DRUG DELIVERY FORMULATIONS 86
7.3.1.1 Solutions 87
7.3.1.2 Reconstituted/lyophilized formulations 87
7.3.1.3 Suspensions 88
7.3.1.4 Emulsions 89
7.3.2 NOVEL DRUG DELIVERY FORMULATIONS 89
7.3.2.1 Colloidal dispersions 91
7.3.2.1.1 Niosomes 91
7.3.2.1.2 Liposomes 92
7.3.2.1.3 Polymeric/mixed micelles 93
7.3.2.1.4 Nanoparticles 93
7.3.2.1.4.1 Solid-lipid nanoparticles 95
7.3.2.1.4.2 Nanosuspensions 95
7.3.2.1.4.3 Nanoemulsions 96
7.3.2.2 Microparticles 96
7.3.2.2.1 Microspheres 97
7.3.2.2.2 Microcapsules 98
7.3.3 LONG-ACTING INJECTION FORMULATIONS 98

8 INJECTABLE DRUG DELIVERY MARKET, BY FORMULATION PACKAGING 100
8.1 INTRODUCTION 101
8.2 AMPULES 102
8.3 VIALS 102
8.4 CARTRIDGES 103
8.5 BOTTLES 103

9 INJECTABLE DRUG DELIVERY MARKET, BY THERAPEUTIC APPLICATION 104
9.1 INTRODUCTION 105
9.2 AUTOIMMUNE DISEASES 105
9.2.1 RHEUMATOID ARTHRITIS 107
9.2.2 MULTIPLE SCLEROSIS (MS) 108
9.2.3 CROHN’S DISEASE 108
9.2.4 PSORIASIS 109
9.2.5 OTHER AUTOIMMUNE DISEASES 110
9.3 HORMONAL DISORDERS 111
9.3.1 DIABETES 112
9.3.2 ANEMIA 113
9.3.3 REPRODUCTIVE HEALTH DISEASE 114
9.3.4 ANTITHROMBOTIC/THROMBOLYTIC THERAPY 115
9.3.5 OSTEOPOROSIS 115
9.3.6 GROWTH HORMONE DEFICIENCY (GHD) 116
9.4 ORPHAN DISEASES 117
9.5 CANCER 118
9.6 OTHER THERAPEUTIC APPLICATIONS 119
9.6.1 PAIN MANAGEMENT 120
9.6.2 ALLERGIES 121
9.6.3 AESTHETIC TREATMENT 122
9.6.4 HEPATITIS C 123
9.6.5 HEMOPHILIA 124

10 INJECTABLE DRUG DELIVERY MARKET, BY USAGE PATTERN 125
10.1 INTRODUCTION 126
10.2 CURATIVE CARE 126
10.3 IMMUNIZATION 128
10.4 OTHERS 128

11 INJECTABLE DRUG DELIVERY MARKET, BY SITE OF ADMINISTRATION 130
11.1 INTRODUCTION 131
11.2 SKIN (INTRADERMAL AND SUBCUTANEOUS) 132
11.3 CIRCULATORY/MUSCULOSKELETAL SYSTEM (INTRAVENOUS, INTRACARDIAC, INTRAMUSCULAR, AND INTRAPERITONEAL) 133
11.4 ORGANS (INTRAVITREAL AND INTRA-ARTICULAR) 134
11.5 CENTRAL NERVOUS SYSTEM (INTRACEREBRAL AND INTRATHECAL) 135

12 INJECTABLE DRUG DELIVERY MARKET, BY DISTRIBUTION CHANNEL 136
12.1 INTRODUCTION 137
12.2 HOSPITALS 137
12.3 RETAIL PHARMACY STORES 138

13 INJECTABLE DRUG DELIVERY MARKET, BY FACILITY OF USE 139
13.1 INTRODUCTION 140
13.2 HOSPITALS AND CLINICS 141
13.3 HOME CARE SETTINGS 142
13.4 OTHER FACILITIES OF USE 143

14 INJECTABLE DRUG DELIVERY MARKET, BY REGION 144
14.1 INTRODUCTION 145
14.2 NORTH AMERICA 146
14.2.1 U.S. 151
14.2.2 CANADA 155
14.3 EUROPE 160
14.3.1 GERMANY 165
14.3.2 FRANCE 169
14.3.3 U.K. 173
14.3.4 ITALY 177
14.3.5 SPAIN 180
14.3.6 REST OF EUROPE (ROE) 184
14.4 ASIA 188
14.4.1 CHINA 194
14.4.2 JAPAN 197
14.4.3 INDIA 201
14.4.4 REST OF ASIA 206
14.5 REST OF THE WORLD (ROW) 210

15 COMPETITIVE LANDSCAPE 215
15.1 OVERVIEW 215
15.2 MARKET SHARE ANALYSIS 216
15.3 COMPETITIVE SITUATION AND TRENDS 217
15.3.1 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS 218
15.3.2 PRODUCT LAUNCHES, APPROVALS, AND ENHANCEMENTS 218
15.3.1 EXPANSIONS 219
15.3.2 ACQUISITIONS 220

16 COMPANY PROFILES 221
(Introduction, Products & Services, Strategy, & Analyst Insights, Developments, MnM View)*
16.1 INTRODUCTION 221
16.2 BAXTER INTERNATIONAL, INC. 222
16.3 BECTON, DICKINSON AND COMPANY 224
16.4 GERRESHEIMER AG 227
16.5 PFIZER, INC. 230
16.6 SCHOTT AG 233
16.7 ELI LILLY AND COMPANY 236
16.8 SANDOZ (A DIVISION OF NOVARTIS AG) 238
16.9 TERUMO CORPORATION 241
16.10 TEVA PHARMACEUTICAL INDUSTRIES LTD. 243

*Details on MarketsandMarkets view, Introduction, Product & Services, Strategy, & Analyst Insights, New Developments might not be captured in case of unlisted companies.

17 APPENDIX 245
17.1 INSIGHTS FROM INDUSTRY EXPERTS 245
17.2 DISCUSSION GUIDE 246
17.3 OTHER RECENT DEVELOPMENTS 250
17.4 AVAILABLE CUSTOMIZATIONS 251
17.5 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 252
17.6 RT: REAL-TIME MARKET INTELLIGENCE 254
17.7 RELATED REPORTS 255
17.8 AUTHOR DETAILS 256

LIST OF TABLES

TABLE 1 PRODUCT RECALLS (2013–2015) 45
TABLE 2 INJECTABLE DRUGS GOING OFF-PATENT IN THE U.S. 47
TABLE 3 LIST OF REGULATORY AUTHORITIES IN MAJOR COUNTRIES 49
TABLE 4 LIST OF FDA APPROVED IN THE MARKET (2015-2016) 49
TABLE 5 INJECTABLE DRUGS IN PHASE III CLINICAL TRIALS 50
TABLE 6 PRODUCT RECALLS (2015-2016) 50
TABLE 7 INJECTABLE DRUG DELIVERY MARKET SIZE, BY TYPE, 2014–2021 (USD BILLION) 52
TABLE 8 INJECTABLE DRUG DELIVERY DEVICES MARKET SIZE, BY TYPE,
2014–2021 (USD BILLION) 53
TABLE 9 INJECTABLE DRUG DELIVERY DEVICES MARKET SIZE, BY REGION,
2014–2021 (USD BILLION) 53
TABLE 10 CONVENTIONAL INJECTION DEVICES MARKET SIZE, BY REGION,
2014–2021 (USD BILLION) 54
TABLE 11 CONVENTIONAL INJECTION DEVICES MARKET SIZE, BY MATERIAL,
2014–2021 (USD BILLION) 54
TABLE 12 CONVENTIONAL GLASS INJECTION DEVICES MARKET SIZE, BY REGION,
2014–2021 (USD BILLION) 55
TABLE 13 CONVENTIONAL PLASTIC INJECTION DEVICES MARKET SIZE, BY REGION,
2014–2021 (USD BILLION) 56
TABLE 14 CONVENTIONAL INJECTION DEVICES MARKET SIZE, BY PRODUCT,
2014–2021 (USD BILLION) 57
TABLE 15 CONVENTIONAL FILLABLE INJECTION DEVICES MARKET SIZE, BY REGION,
2014–2021 (USD BILLION) 58
TABLE 16 CONVENTIONAL PREFILLED INJECTION DEVICES MARKET SIZE, BY REGION,
2014–2021 (USD BILLION) 58
TABLE 17 CONVENTIONAL INJECTION DEVICES MARKET SIZE, BY USABILITY,
2014–2021 (USD BILLION) 59
TABLE 18 CONVENTIONAL REUSABLE INJECTION DEVICES MARKET SIZE, BY REGION,
2014–2021 (USD BILLION) 60
TABLE 19 CONVENTIONAL DISPOSABLE INJECTION DEVICES MARKET SIZE, BY REGION, 2014–2021 (USD BILLION) 61
TABLE 20 SELF-INJECTION DEVICES MARKET SIZE, BY TYPE, 2014–2021 (USD BILLION) 62
TABLE 21 SELF-INJECTION DEVICES MARKET SIZE, BY REGION, 2014–2021 (USD BILLION) 62
TABLE 22 NEEDLE-FREE INJECTORS MARKET SIZE, BY REGION, 2014–2021 (USD BILLION) 63
TABLE 23 NEEDLE-FREE INJECTORS MARKET SIZE, BY PRODUCT, 2014–2021 (USD BILLION) 63
TABLE 24 FILLABLE NEEDLE-FREE INJECTORS MARKET SIZE, BY REGION,
2014–2021 (USD BILLION) 64
TABLE 25 PREFILLED NEEDLE-FREE INJECTORS MARKET SIZE, BY REGION,
2014–2021 (USD BILLION) 64
TABLE 26 NEEDLE-FREE INJECTORS MARKET SIZE, BY TECHNOLOGY,
2014–2021 (USD MILLION) 65
TABLE 27 LIST OF SOME OF THE NEEDLE-FREE JET INJECTORS AVAILABLE IN THE MARKET 65
TABLE 28 JET-BASED NEEDLE-FREE INJECTORS MARKET SIZE, BY REGION,
2014–2021 (USD BILLION) 66
TABLE 29 LIST OF SOME OF THE NEEDLE-FREE SPRING-BASED INJECTORS AVAILABLE IN THE MARKET 66
TABLE 30 SPRING-BASED NEEDLE-FREE INJECTORS MARKET SIZE, BY REGION,
2014–2021 (USD BILLION) 67
TABLE 31 LASER-POWERED NEEDLE-FREE INJECTORS MARKET SIZE, BY REGION,
2014–2021 (USD MILLION) 67
TABLE 32 VIBRATION-BASED NEEDLE-FREE INJECTORS MARKET SIZE, BY REGION,
2014–2021 (USD MILLION) 68
TABLE 33 NEEDLE-FREE INJECTORS MARKET SIZE, BY USABILITY,
2014–2021 (USD BILLION) 68
TABLE 34 REUSABLE NEEDLE-FREE INJECTORS MARKET SIZE, BY REGION,
2014–2021 (USD BILLION) 69
TABLE 35 DISPOSABLE NEEDLE-FREE INJECTORS MARKET SIZE, BY REGION,
2014–2021 (USD BILLION) 70
TABLE 36 AUTOINJECTORS MARKET SIZE, BY REGION, 2014–2021 (USD BILLION) 70
TABLE 37 AUTOINJECTORS MARKET SIZE, BY PRODUCT, 2014–2021 (USD BILLION) 71
TABLE 38 FILLABLE AUTOINJECTORS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 71
TABLE 39 PREFILLED AUTOINJECTORS MARKET SIZE, BY REGION,
2014–2021 (USD MILLION) 72
TABLE 40 AUTOINJECTORS MARKET SIZE, BY TECHNOLOGY, 2014–2021 (USD BILLION) 72
TABLE 41 AUTOMATED AUTOINJECTORS MARKET SIZE, BY REGION,
2014–2021 (USD BILLION) 73
TABLE 42 MANUAL AUTOINJECTORS MARKET SIZE, BY REGION, 2014–2021 (USD BILLION) 74
TABLE 43 AUTOINJECTORS MARKET SIZE, BY DESIGN, 2014–2021 (USD BILLION) 74
TABLE 44 STANDARDIZED AUTOINJECTORS MARKET SIZE, BY REGION,
2014–2021 (USD BILLION) 75
TABLE 45 CUSTOMIZED AUTOINJECTORS MARKET SIZE, BY REGION,
2014–2021 (USD BILLION) 75
TABLE 46 AUTOINJECTOR MARKET SIZE, BY USABILITY, 2014–2021 (USD BILLION) 76
TABLE 47 REUSABLE AUTOINJECTORS MARKET SIZE, BY REGION, 2014–2021 (USD BILLION) 76
TABLE 48 DISPOSABLE AUTOINJECTORS MARKET SIZE, BY REGION,
2014–2021 (USD BILLION) 77
TABLE 49 PEN INJECTORS MARKET SIZE, BY REGION, 2014–2021 (USD BILLION) 78
TABLE 50 COMMERCIALLY AVAILABLE PEN INJECTORS 78
TABLE 51 PEN INJECTORS MARKET SIZE, BY PRODUCT, 2014–2021 (USD BILLION) 78
TABLE 52 SINGLE-CHAMBERED PEN INJECTORS MARKET SIZE, BY REGION,
2014–2021 (USD BILLION) 79
TABLE 53 COMMERCIALLY AVAILABLE DUAL-CHAMBERED PEN INJECTORS 79
TABLE 54 DUAL-CHAMBERED PEN INJECTORS MARKET SIZE, BY REGION,
2014–2021 (USD BILLION) 80
TABLE 55 PEN INJECTORS MARKET SIZE, BY DESIGN, 2014–2021 (USD BILLION) 80
TABLE 56 STANDARD PEN INJECTORS MARKET SIZE, BY REGION, 2014–2021 (USD BILLION) 81
TABLE 57 CUSTOMIZED PEN INJECTORS MARKET SIZE, BY REGION,
2014–2021 (USD BILLION) 81
TABLE 58 PEN INJECTORS MARKET SIZE, BY USABILITY, 2014–2021 (USD BILLION) 82
TABLE 59 REUSABLE PEN INJECTORS MARKET SIZE, BY REGION, 2014–2021 (USD BILLION) 82
TABLE 60 DISPOSABLE PEN INJECTORS MARKET SIZE, BY REGION,
2014–2021 (USD BILLION) 83
TABLE 61 WEARABLE INJECTORS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 83
TABLE 62 OTHER DEVICES MARKET SIZE, BY REGION, 2014–2021 (USD BILLION) 84
TABLE 63 INJECTABLE DRUG DELIVERY FORMULATIONS MARKET SIZE, BY TYPE,
2014–2021 (USD BILLION) 85
TABLE 64 INJECTABLE DRUG DELIVERY FORMULATIONS MARKET SIZE, BY REGION,
2014–2021 (USD BILLION) 85
TABLE 65 CONVENTIONAL DRUG DELIVERY FORMULATIONS MARKET SIZE, BY TYPE,
2014–2021 (USD BILLION) 86
TABLE 66 CONVENTIONAL DRUG DELIVERY FORMULATIONS MARKET SIZE, BY REGION, 2014–2021 (USD BILLION) 86
TABLE 67 SOLUTIONS MARKET SIZE, BY REGION, 2014–2021 (USD BILLION) 87
TABLE 68 RECONSTITUTED/LYOPHILIZED FORMULATIONS MARKET SIZE, BY REGION,
2014–2021 (USD BILLION) 88
TABLE 69 SUSPENSIONS MARKET SIZE, BY REGION, 2014–2021 (USD BILLION) 88
TABLE 70 EMULSIONS MARKET SIZE, BY REGION, 2014–2021 (USD BILLION) 89
TABLE 71 NOVEL DRUG DELIVERY FORMULATIONS MARKET SIZE, BY TYPE,
2014–2021 (USD BILLION) 90
TABLE 72 NOVEL DRUG DELIVERY FORMULATIONS MARKET SIZE, BY REGION,
2014–2021 (USD BILLION) 90
TABLE 73 COLLOIDAL DISPERSIONS MARKET SIZE, BY TYPE, 2014–2021 (USD BILLION) 91
TABLE 74 COLLOIDAL DISPERSIONS MARKET SIZE, BY REGION, 2014–2021 (USD BILLION) 91
TABLE 75 NIOSOMES MARKET SIZE, BY REGION, 2014–2021 (USD BILLION) 92
TABLE 76 LIPOSOMES MARKET SIZE, BY REGION, 2014–2021 (USD BILLION) 92
TABLE 77 POLYMERIC/MIXED MICELLES MARKET SIZE, BY REGION,
2014–2021 (USD BILLION) 93
TABLE 78 NANOPARTICLES MARKET SIZE, BY TYPE, 2014–2021 (USD BILLION) 94
TABLE 79 NANOPARTICLES MARKET SIZE, BY REGION, 2014–2021 (USD BILLION) 94
TABLE 80 SOLID-LIPID NANOPARTICLES MARKET SIZE, BY REGION,
2014–2021 (USD BILLION) 95
TABLE 81 NANOSUSPENSIONS MARKET SIZE, BY REGION, 2014–2021 (USD BILLION) 95
TABLE 82 NANOEMULSIONS MARKET SIZE, BY REGION, 2014–2021 (USD MILLION) 96
TABLE 83 MICROPARTICLES MARKET SIZE, BY TYPE, 2014–2021 (USD BILLION) 96
TABLE 84 MICROPARTICLES MARKET SIZE, BY REGION, 2014–2021 (USD BILLION) 97
TABLE 85 MICROSPHERES MARKET SIZE, BY REGION, 2014–2021 (USD BILLION) 97
TABLE 86 MICROCAPSULES MARKET SIZE, BY REGION, 2014–2021 (USD BILLION) 98
TABLE 87 LONG-ACTING INJECTION FORMULATIONS MARKET SIZE, BY REGION,
2014–2021 (USD BILLION) 99
TABLE 88 INJECTABLE DRUG DELIVERY MARKET SIZE, BY FORMULATION PACKAGING,
2014–2021 (USD BILLION) 101
TABLE 89 INJECTABLE DRUG DELIVERY MARKET SIZE FOR FORMULATION PACKAGING,
BY REGION, 2014–2021 (USD BILLION) 101
TABLE 90 INJECTABLE DRUG DELIVERY MARKET SIZE FOR AMPULES, BY REGION,
2014–2021 (USD BILLION) 102
TABLE 91 INJECTABLE DRUG DELIVERY MARKET SIZE FOR VIALS, BY REGION,
2014–2021 (USD BILLION) 102
TABLE 92 INJECTABLE DRUG DELIVERY MARKET SIZE FOR CARTRIDGES, BY REGION,
2014–2021 (USD BILLION) 103
TABLE 93 INJECTABLE DRUG DELIVERY MARKET SIZE FOR BOTTLES, BY REGION,
2014–2021 (USD BILLION) 103
TABLE 94 INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014–2021 (USD BILLION) 105
TABLE 95 INJECTABLE DRUG DELIVERY MARKET SIZE FOR AUTOIMMUNE DISEASES,
BY INDICATION, 2014–2021 (USD BILLION) 106
TABLE 96 INJECTABLE DRUG DELIVERY MARKET SIZE FOR AUTOIMMUNE DISEASES,
BY REGION, 2014–2021 (USD BILLION) 106
TABLE 97 INJECTABLE DRUG DELIVERY MARKET SIZE FOR RHEUMATOID ARTHRITIS,
BY REGION, 2014–2021 (USD BILLION) 107
TABLE 98 INJECTABLE DRUG DELIVERY MARKET SIZE FOR MULTIPLE SCLEROSIS,
BY REGION, 2014–2021 (USD BILLION) 108
TABLE 99 INJECTABLE DRUG DELIVERY MARKET SIZE FOR CROHN’S DISEASE,
BY REGION, 2014–2021 (USD BILLION) 109
TABLE 100 INJECTABLE DRUG DELIVERY MARKET SIZE FOR PSORIASIS, BY REGION,
2014–2021 (USD BILLION) 110
TABLE 101 INJECTABLE DRUG DELIVERY MARKET SIZE FOR OTHER AUTOIMMUNE DISEASES, BY REGION, 2014–2021 (USD BILLION) 110
TABLE 102 INJECTABLE DRUG DELIVERY MARKET SIZE FOR HORMONAL DISORDERS,
BY INDICATION, 2014–2021 (USD BILLION) 111
TABLE 103 INJECTABLE DRUG DELIVERY MARKET SIZE FOR HORMONAL DISORDERS,
BY REGION, 2014–2021 (USD BILLION) 111
TABLE 104 INJECTABLE DRUG DELIVERY MARKET SIZE FOR DIABETES, BY REGION,
2014–2021 (USD BILLION) 112
TABLE 105 INJECTABLE DRUG DELIVERY MARKET SIZE FOR ANEMIA, BY REGION,
2014–2021 (USD BILLION) 113
TABLE 106 INJECTABLE DRUG DELIVERY MARKET SIZE FOR REPRODUCTIVE HEALTH DISEASE, BY REGION, 2014–2021 (USD BILLION) 114
TABLE 107 INJECTABLE DRUG DELIVERY MARKET SIZE FOR ANTITHROMBOTIC/THROMBOLYTIC THERAPY, BY REGION,
2014–2021 (USD BILLION) 115
TABLE 108 INJECTABLE DRUG DELIVERY MARKET SIZE FOR OSTEOPOROSIS,
BY REGION, 2014-2021 (USD BILLION) 116
TABLE 109 INJECTABLE DRUG DELIVERY MARKET SIZE FOR GROWTH HORMONE DEFICIENCY, BY REGION, 2014-2021 (USD BILLION) 117
TABLE 110 INJECTABLE DRUG DELIVERY MARKET SIZE FOR ORPHAN DISEASES,
BY REGION, 2014-2021 (USD BILLION) 118
TABLE 111 INJECTABLE DRUG DELIVERY MARKET SIZE FOR CANCER, BY REGION,
2014-2021 (USD BILLION) 119
TABLE 112 INJECTABLE DRUG DELIVERY MARKET SIZE FOR OTHER THERAPEUTIC APPLICATIONS, BY INDICATION, 2014-2021 (USD BILLION) 119
TABLE 113 INJECTABLE DRUG DELIVERY MARKET SIZE FOR OTHER THERAPEUTIC APPLICATIONS, BY REGION, 2014-2021 (USD BILLION) 120
TABLE 114 INJECTABLE DRUG DELIVERY MARKET SIZE FOR PAIN MANAGEMENT, BY REGION, 2014-2021 (USD BILLION) 120
TABLE 115 INJECTABLE DRUG DELIVERY MARKET SIZE FOR ALLERGIES, BY REGION,
2014-2021 (USD BILLION) 121
TABLE 116 INJECTABLE DRUG DELIVERY MARKET SIZE FOR AESTHETIC TREATMENTS,
BY REGION, 2014-2021 (USD MILLION) 122
TABLE 117 INJECTABLE DRUG DELIVERY MARKET SIZE FOR HEPATITIS C, BY REGION,
2014-2021 (USD BILLION) 123
TABLE 118 INJECTABLE DRUG DELIVERY MARKET SIZE FOR HEMOPHILIA, BY REGION,
2014-2021 (USD MILLION) 124
TABLE 119 INJECTABLE DRUG DELIVERY MARKET SIZE, BY USAGE PATTERN,
2014–2021 (USD BILLION) 126
TABLE 120 PIPELINE CURATIVE CARE DRUGS (2016-2020) 127
TABLE 121 INJECTABLE DRUG DELIVERY MARKET SIZE FOR CURATIVE CARE,
BY REGION, 2014–2021 (USD BILLION) 127
TABLE 122 INJECTABLE DRUG DELIVERY MARKET SIZE FOR IMMUNIZATION,
BY REGION, 2014–2021 (USD BILLION) 128
TABLE 123 INJECTABLE DRUG DELIVERY MARKET SIZE FOR OTHER USAGE PATTERNS,
BY REGION, 2014–2021 (USD BILLION) 129
TABLE 124 INJECTABLE DRUG DELIVERY MARKET SIZE, BY SITE OF ADMINISTRATION,
2014–2021 (USD BILLION) 131
TABLE 125 MARKET FOR INJECTABLE DRUG DELIVERY THROUGH SKIN, BY REGION,
2014–2021 (USD BILLION) 132
TABLE 126 MARKET FOR INJECTABLE DRUG DELIVERY THROUGH CIRCULATORY/MUSCULOSKELETAL SYSTEM, BY REGION,
2014–2021 (USD BILLION) 133
TABLE 127 MARKET FOR INJECTABLE DRUG DELIVERY THROUGH ORGANS, BY REGION, 2014–2021 (USD BILLION) 134
TABLE 128 MARKET FOR INJECTABLE DRUG DELIVERY THROUGH CENTRAL NERVOUS SYSTEM, BY REGION, 2014–2021 (USD BILLION) 135
TABLE 129 INJECTABLE DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL,
2014–2021 (USD BILLION) 137
TABLE 130 INJECTABLE DRUG DELIVERY MARKET SIZE FOR HOSPITALS, BY REGION,
2014–2021 (USD MILLION) 137
TABLE 131 INJECTABLE DRUG DELIVERY MARKET SIZE FOR RETAIL PHARMACY STORES,
BY REGION, 2014–2021 (USD MILLION) 138
TABLE 132 INJECTABLE DRUG DELIVERY MARKET SIZE, BY FACILITY OF USE,
2014–2021 (USD BILLION) 140
TABLE 133 INJECTABLE DRUG DELIVERY MARKET SIZE FOR HOSPITALS AND CLINICS,
BY REGION, 2014–2021 (USD BILLION) 141
TABLE 134 INJECTABLE DRUG DELIVERY MARKET SIZE FOR HOME CARE SETTINGS,
BY REGION, 2014–2021 (USD BILLION) 142
TABLE 135 INJECTABLE DRUG DELIVERY MARKET SIZE FOR OTHER FACILITIES OF USE,
BY REGION, 2014–2021 (USD BILLION) 143
TABLE 136 INJECTABLE DRUG DELIVERY MARKET SIZE, BY REGION,
2014-2021 (USD BILLION) 145
TABLE 137 NORTH AMERICA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY COUNTRY,
2014-2021 (USD BILLION) 146
TABLE 138 NORTH AMERICA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY TYPE,
2014–2021 (USD BILLION) 148
TABLE 139 NORTH AMERICA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE,
2014-2021 (USD BILLION) 148
TABLE 140 NORTH AMERICA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FORMULATION, 2014-2021 (USD BILLION) 148
TABLE 141 NORTH AMERICA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD BILLION) 149
TABLE 142 NORTH AMERICA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY USAGE PATTERN, 2014-2021 (USD BILLION) 149
TABLE 143 NORTH AMERICA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY SITE OF ADMINISTRATION, 2014-2021 (USD BILLION) 150
TABLE 144 NORTH AMERICA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FACILITY OF USE, 2014-2021 (USD BILLION) 150
TABLE 145 NORTH AMERICA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FORMULATION PACKAGING, 2014-2021 (USD BILLION) 150
TABLE 146 NORTH AMERICA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2014-2021 (USD BILLION) 151
TABLE 147 U.S.: INJECTABLE DRUG DELIVERY MARKET SIZE, BY TYPE,
2014-2021 (USD BILLION) 152
TABLE 148 U.S.: INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE,
2014-2021 (USD BILLION) 152
TABLE 149 U.S.: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FORMULATION,
2014-2021 (USD BILLION) 152
TABLE 150 U.S.: INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD BILLION) 153
TABLE 151 U.S.: INJECTABLE DRUG DELIVERY MARKET SIZE, BY USAGE PATTERN,
2014-2021 (USD BILLION) 153
TABLE 152 U.S.: INJECTABLE DRUG DELIVERY MARKET SIZE, BY SITE OF ADMINISTRATION, 2014-2021 (USD BILLION) 154
TABLE 153 U.S.: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FACILITY OF USE,
2014-2021 (USD BILLION) 154
TABLE 154 U.S.: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FORMULATION PACKAGING, 2014-2021 (USD BILLION) 154
TABLE 155 U.S.: INJECTABLE DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2014-2021 (USD BILLION) 155
TABLE 156 LIST OF INJECTABLES LAUNCHED IN CANADA (2014-2015) 156
TABLE 157 CANADA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY TYPE,
2014-2021 (USD BILLION) 156
TABLE 158 CANADA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE,
2014-2021 (USD BILLION) 156
TABLE 159 CANADA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FORMULATION,
2014-2021 (USD BILLION) 157
TABLE 160 CANADA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD BILLION) 157
TABLE 161 CANADA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY USAGE PATTERN,
2014-2021 (USD BILLION) 157
TABLE 162 CANADA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY SITE OF ADMINISTRATION, 2014-2021 (USD BILLION) 158
TABLE 163 CANADA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FACILITY OF USE,
2014-2021 (USD BILLION) 158
TABLE 164 CANADA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FORMULATION PACKAGING, 2014-2021 (USD BILLION) 159
TABLE 165 CANADA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2014-2021 (USD BILLION) 159
TABLE 166 EUROPE: INJECTABLE DRUG DELIVERY MARKET SIZE, BY COUNTRY,
2014-2021 (USD BILLION) 162
TABLE 167 EUROPE: INJECTABLE DRUG DELIVERY MARKET SIZE, BY TYPE,
2014-2021 (USD BILLION) 162
TABLE 168 EUROPE: INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE,
2014-2021 (USD BILLION) 162
TABLE 169 EUROPE: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FORMULATION,
2014-2021 (USD BILLION) 163
TABLE 170 EUROPE: INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD BILLION) 163
TABLE 171 EUROPE: INJECTABLE DRUG DELIVERY MARKET SIZE, BY USAGE PATTERN,
2014-2021 (USD BILLION) 164
TABLE 172 EUROPE: INJECTABLE DRUG DELIVERY MARKET SIZE, BY SITE OF ADMINISTRATION, 2014-2021 (USD BILLION) 164
TABLE 173 EUROPE: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FACILITY OF USE,
2014-2021 (USD BILLION) 164
TABLE 174 EUROPE: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FORMULATION PACKAGING, 2014-2021 (USD BILLION) 165
TABLE 175 EUROPE: INJECTABLE DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2014-2021 (USD BILLION) 165
TABLE 176 GERMANY: INJECTABLE DRUG DELIVERY MARKET SIZE, BY TYPE,
2014-2021 (USD BILLION) 166
TABLE 177 GERMANY: INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE,
2014-2021 (USD BILLION) 166
TABLE 178 GERMANY: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FORMULATION,
2014-2021 (USD BILLION) 166
TABLE 179 GERMANY: INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD BILLION) 167
TABLE 180 GERMANY: INJECTABLE DRUG DELIVERY MARKET SIZE, BY USAGE PATTERN,
2014-2021 (USD BILLION) 167
TABLE 181 GERMANY: INJECTABLE DRUG DELIVERY MARKET SIZE, BY SITE OF ADMINISTRATION, 2014-2021 (USD BILLION) 167
TABLE 182 GERMANY: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FACILITY OF USE,
2014-2021 (USD BILLION) 168
TABLE 183 GERMANY: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FORMULATION PACKAGING, 2014-2021 (USD BILLION) 168
TABLE 184 GERMANY: INJECTABLE DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2014-2021 (USD BILLION) 169
TABLE 185 FRANCE: INJECTABLE DRUG DELIVERY MARKET SIZE, BY TYPE,
2014-2021 (USD BILLION) 169
TABLE 186 FRANCE: INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE,
2014-2021 (USD BILLION) 170
TABLE 187 FRANCE: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FORMULATION,
2014-2021 (USD BILLION) 170
TABLE 188 FRANCE: INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD BILLION) 170
TABLE 189 FRANCE: INJECTABLE DRUG DELIVERY MARKET SIZE, BY USAGE PATTERN,
2014-2021 (USD BILLION) 171
TABLE 190 FRANCE: INJECTABLE DRUG DELIVERY MARKET SIZE, BY SITE OF ADMINISTRATION, 2014-2021 (USD BILLION) 171
TABLE 191 FRANCE: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FACILITY OF USE,
2014-2021 (USD BILLION) 172
TABLE 192 FRANCE: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FORMULATION PACKAGING, 2014-2021 (USD BILLION) 172
TABLE 193 FRANCE: INJECTABLE DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2014-2021 (USD BILLION) 172
TABLE 194 U.K.: INJECTABLE DRUG DELIVERY MARKET SIZE, BY TYPE,
2014-2021 (USD BILLION) 173
TABLE 195 U.K.: INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE,
2014-2021 (USD BILLION) 173
TABLE 196 U.K.: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FORMULATION,
2014-2021 (USD BILLION) 174
TABLE 197 U.K.: INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD BILLION) 174
TABLE 198 U.K.: INJECTABLE DRUG DELIVERY MARKET SIZE, BY USAGE PATTERN,
2014-2021 (USD BILLION) 174
TABLE 199 U.K.: INJECTABLE DRUG DELIVERY MARKET SIZE, BY SITE OF ADMINISTRATION, 2014-2021 (USD BILLION) 175
TABLE 200 U.K.: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FACILITY OF USE,
2014-2021 (USD BILLION) 175
TABLE 201 U.K.: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FORMULATION PACKAGING, 2014-2021 (USD BILLION) 176
TABLE 202 U.K.: INJECTABLE DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2014-2021 (USD BILLION) 176
TABLE 203 ITALY: INJECTABLE DRUG DELIVERY MARKET SIZE, BY TYPE,
2014-2021 (USD BILLION) 177
TABLE 204 ITALY: INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE,
2014-2021 (USD MILLION) 177
TABLE 205 ITALY: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FORMULATION,
2014-2021 (USD BILLION) 178
TABLE 206 ITALY: INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD BILLION) 178
TABLE 207 ITALY: INJECTABLE DRUG DELIVERY MARKET SIZE, BY USAGE PATTERN,
2014-2021 (USD BILLION) 178
TABLE 208 ITALY: INJECTABLE DRUG DELIVERY MARKET SIZE, BY SITE OF ADMINISTRATION, 2014-2021 (USD BILLION) 179
TABLE 209 ITALY: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FACILITY OF USE,
2014-2021 (USD BILLION) 179
TABLE 210 ITALY: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FORMULATION PACKAGING, 2014-2021 (USD BILLION) 180
TABLE 211 ITALY: INJECTABLE DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2014-2021 (USD BILLION) 180
TABLE 212 SPAIN: INJECTABLE DRUG DELIVERY MARKET SIZE, BY TYPE,
2014-2021 (USD BILLION) 181
TABLE 213 SPAIN: INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE,
2014-2021 (USD MILLION) 181
TABLE 214 SPAIN: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FORMULATION,
2014-2021 (USD BILLION) 181
TABLE 215 SPAIN: INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD BILLION) 182
TABLE 216 SPAIN: INJECTABLE DRUG DELIVERY MARKET SIZE, BY USAGE PATTERN,
2014-2021 (USD BILLION) 182
TABLE 217 SPAIN: INJECTABLE DRUG DELIVERY MARKET SIZE, BY SITE OF ADMINISTRATION, 2014-2021 (USD BILLION) 183
TABLE 218 SPAIN: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FACILITY OF USE,
2014-2021 (USD BILLION) 183
TABLE 219 SPAIN: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FORMULATION PACKAGING, 2014-2021 (USD BILLION) 183
TABLE 220 SPAIN: INJECTABLE DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2014-2021 (USD BILLION) 184
TABLE 221 ROE: INJECTABLE DRUG DELIVERY MARKET SIZE, BY TYPE,
2014-2021 (USD BILLION) 184
TABLE 222 ROE: INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE,
2014-2021 (USD BILLION) 185
TABLE 223 ROE: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FORMULATION,
2014-2021 (USD BILLION) 185
TABLE 224 ROE: INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD BILLION) 185
TABLE 225 ROE: INJECTABLE DRUG DELIVERY MARKET SIZE, BY USAGE PATTERN,
2014-2021 (USD BILLION) 186
TABLE 226 ROE: INJECTABLE DRUG DELIVERY MARKET SIZE, BY SITE OF ADMINISTRATION, 2014-2021 (USD BILLION) 186
TABLE 227 ROE: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FACILITY OF USE,
2014-2021 (USD BILLION) 187
TABLE 228 ROE: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FORMULATION PACKAGING, 2014-2021 (USD BILLION) 187
TABLE 229 ROE: INJECTABLE DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2014-2021 (USD BILLION) 187
TABLE 230 ASIA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY COUNTRY,
2014-2021 (USD BILLION) 190
TABLE 231 ASIA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY TYPE,
2014-2021 (USD BILLION) 190
TABLE 232 ASIA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE,
2014-2021 (USD BILLION) 190
TABLE 233 ASIA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FORMULATION,
2014-2021 (USD BILLION) 191
TABLE 234 ASIA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD BILLION) 191
TABLE 235 ASIA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY USAGE PATTERN,
2014-2021 (USD BILLION) 191
TABLE 236 ASIA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY SITE OF ADMINISTRATION, 2014-2021 (USD BILLION) 192
TABLE 237 ASIA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FACILITY OF USE,
2014-2021 (USD BILLION) 192
TABLE 238 ASIA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FORMULATION PACKAGING, 2014-2021 (USD BILLION) 193
TABLE 239 ASIA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2014-2021 (USD BILLION) 193
TABLE 240 CHINA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY TYPE,
2014–2021 (USD BILLION) 194
TABLE 241 CHINA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE,
2014-2021 (USD BILLION) 194
TABLE 242 CHINA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FORMULATION,
2014-2021 (USD BILLION) 195
TABLE 243 CHINA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD BILLION) 195
TABLE 244 CHINA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY USAGE PATTERN,
2014-2021 (USD BILLION) 195
TABLE 245 CHINA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY SITE OF ADMINISTRATION, 2014-2021 (USD BILLION) 196
TABLE 246 CHINA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FACILITY OF USE,
2014-2021 (USD BILLION) 196
TABLE 247 CHINA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FORMULATION PACKAGING, 2014-2021 (USD BILLION) 197
TABLE 248 CHINA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2014-2021 (USD BILLION) 197
TABLE 249 JAPAN: INJECTABLE DRUG DELIVERY MARKET SIZE, BY TYPE,
2014–2021 (USD BILLION) 198
TABLE 250 JAPAN: INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE,
2014-2021 (USD BILLION) 198
TABLE 251 JAPAN: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FORMULATION,
2014-2021 (USD BILLION) 199
TABLE 252 JAPAN: INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD BILLION) 199
TABLE 253 JAPAN: INJECTABLE DRUG DELIVERY MARKET SIZE, BY USAGE PATTERN,
2014-2021 (USD BILLION) 199
TABLE 254 JAPAN: INJECTABLE DRUG DELIVERY MARKET SIZE, BY SITE OF ADMINISTRATION, 2014-2021 (USD BILLION) 200
TABLE 255 JAPAN: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FACILITY OF USE,
2014-2021 (USD BILLION) 200
TABLE 256 JAPAN: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FORMULATION PACKAGING, 2014-2021 (USD BILLION) 201
TABLE 257 JAPAN: INJECTABLE DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2014-2021 (USD BILLION) 201
TABLE 258 INDIA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY TYPE,
2014–2021 (USD BILLION) 202
TABLE 259 INDIA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE,
2014-2021 (USD BILLION) 202
TABLE 260 INDIA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FORMULATION,
2014-2021 (USD BILLION) 203
TABLE 261 INDIA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD BILLION) 203
TABLE 262 INDIA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY USAGE PATTERN,
2014-2021 (USD BILLION) 203
TABLE 263 INDIA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY SITE OF ADMINISTRATION, 2014-2021 (USD BILLION) 204
TABLE 264 INDIA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FACILITY OF USE,
2014-2021 (USD BILLION) 204
TABLE 265 INDIA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FORMULATION PACKAGING, 2014-2021 (USD BILLION) 205
TABLE 266 INDIA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2014-2021 (USD BILLION) 205
TABLE 267 ROA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY TYPE,
2014–2021 (USD BILLION) 206
TABLE 268 ROA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE,
2014-2021 (USD MILLION) 206
TABLE 269 ROA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FORMULATION,
2014-2021 (USD BILLION) 207
TABLE 270 ROA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD BILLION) 207
TABLE 271 ROA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY USAGE PATTERN,
2014-2021 (USD MILLION) 207
TABLE 272 ROA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY SITE OF ADMINISTRATION, 2014-2021 (USD BILLION) 208
TABLE 273 ROA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FACILITY OF USE,
2014-2021 (USD BILLION) 208
TABLE 274 ROA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FORMULATION PACKAGING, 2014-2021 (USD BILLION) 209
TABLE 275 ROA: INJECTABLE DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2014-2021 (USD BILLION) 209
TABLE 276 ROW: INJECTABLE DRUG DELIVERY MARKET SIZE, BY TYPE,
2014-2021 (USD BILLION) 211
TABLE 277 ROW: INJECTABLE DRUG DELIVERY MARKET SIZE, BY DEVICE,
2014-2021 (USD BILLION) 211
TABLE 278 ROW: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FORMULATION,
2014-2021 (USD BILLION) 211
TABLE 279 ROW: INJECTABLE DRUG DELIVERY MARKET SIZE, BY THERAPEUTIC APPLICATION, 2014-2021 (USD BILLION) 212
TABLE 280 ROW: INJECTABLE DRUG DELIVERY MARKET SIZE, BY USAGE PATTERN,
2014-2021 (USD BILLION) 212
TABLE 281 ROW: INJECTABLE DRUG DELIVERY MARKET SIZE, BY SITE OF ADMINISTRATION, 2014–2021 (USD BILLION) 213
TABLE 282 ROW: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FACILITY OF USE,
2014-2021 (USD BILLION) 213
TABLE 283 ROW: INJECTABLE DRUG DELIVERY MARKET SIZE, BY FORMULATION PACKAGING, 2014-2021 (USD BILLION) 213
TABLE 284 ROW: INJECTABLE DRUG DELIVERY MARKET SIZE, BY DISTRIBUTION CHANNEL, 2014-2021 (USD BILLION) 214
TABLE 285 PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS (2013–2016) 218
TABLE 286 PRODUCT LAUNCHES, APPROVALS, AND ENHANCEMENTS (2013–2016) 218
TABLE 287 EXPANSIONS (2013–2016) 219
TABLE 288 ACQUISITIONS (2013–2016) 220


LIST OF FIGURES

FIGURE 1 INJECTABLE DRUG DELIVERY MARKET 25
FIGURE 2 RESEARCH DESIGN 27
FIGURE 3 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 29
FIGURE 4 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 29
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY, DESIGNATION AND REGION 30
FIGURE 6 DATA TRIANGULATION METHODOLOGY 31
FIGURE 7 INJECTABLE DRUG DELIVERY MARKET SNAPSHOT, BY FORMULATION
2016 VS. 2021 (USD BILLION) 34
FIGURE 8 INJECTABLE DRUG DELIVERY MARKET, BY FACILITY OF USE
2016 VS. 2021 (USD BILLION) 35
FIGURE 9 INJECTABLE DRUG DELIVERY MARKET, BY THERAPEUTIC APPLICATION,
2016 VS 2021 (USD BILLION) 35
FIGURE 10 INJECTABLE DRUG DELIVERY MARKET, BY REGION (2016-2021) 36
FIGURE 11 INCREASING USE OF BIOLOGIC DRUGS AND RISING PREVALENCE OF CHRONIC DISEASES TO DRIVE MARKET GROWTH 37
FIGURE 12 HOSPITALS AND CLINICS TO DOMINATE THE MARKET IN 2016 37
FIGURE 13 SKIN SEGMENT TO COMMAND THE LARGEST MARKET SHARE IN 2016 38
FIGURE 14 AMPULES TO DOMINATE THE INJECTABLE DRUG DELIVERY MARKET, IN 2016 38
FIGURE 15 CHINA TO REGISTER HIGHEST GROWTH RATE DURING THE FORECAST PERIOD 39
FIGURE 16 INJECTABLE DRUG DELIVERY MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 41
FIGURE 17 NORTH AMERICA: INJECTABLE DRUG DELIVERY MARKET SNAPSHOT 147
FIGURE 18 EUROPE: INJECTABLE DRUG DELIVERY MARKET SNAPSHOT 161
FIGURE 19 ASIA: INJECTABLE DRUG DELIVERY MARKET SNAPSHOT 189
FIGURE 20 REST OF THE WORLD: INJECTABLE DRUG DELIVERY MARKET SNAPSHOT 210
FIGURE 21 KEY PLAYERS ADOPTED INORGANIC GROWTH STRATEGIES BETWEEN
2013 AND 2016 215
FIGURE 22 INJECTABLE DRUG DELIVERY MARKET EVOLUTION FRAMEWORK, 2013–2016 216
FIGURE 23 GLOBAL INJECTABLE DRUG DELIVERY MARKET SHARE ANALYSIS, 2015 216
FIGURE 24 BATTLE FOR MARKET SHARE: PARTNERSHIPS, AGREEMENTS, AND COLLABORATIONS ARE THE KEY STRATEGIES ADOPTED BY MARKET PLAYERS 217
FIGURE 25 GEOGRAPHIC BENCHMARKING OF TOP 5 PLAYERS 221
FIGURE 26 BAXTER INTERNATIONAL, INC.: COMPANY SNAPSHOT (2015) 222
FIGURE 27 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2015) 224
FIGURE 28 GERRESHEIMER AG: COMPANY SNAPSHOT (2015) 227
FIGURE 29 PFIZER, INC.: COMPANY SNAPSHOT (2015) 230
FIGURE 30 SCHOTT AG: COMPANY SNAPSHOT (2015) 233
FIGURE 31 ELI LILLY AND COMPANY: COMPANY SNAPSHOT (2015) 236
FIGURE 32 SANDOZ: COMPANY SNAPSHOT (2015) 238
FIGURE 33 TERUMO CORPORATION: COMPANY SNAPSHOT (2015) 241
FIGURE 34 TEVA PHARMACEUTICAL INDUSTRIES LTD.: COMPANY SNAPSHOT (2015) 243


【レポートのキーワード】

注射可能薬剤送達、薬剤送達装置、治療、医療、投与経路、病院、患者

★調査レポート[注射可能薬剤送達の世界市場予測(~2021年)] ( Injectable Drug Delivery Market by Type (Device, Formulation), Therapeutic (Cancer), Usage Pattern (Immunization), Administration (Skin, Musculoskeletal), Distribution Channel (Hospital), Patient Care Setting (Hospital, Home Care) - Forecast to 2021 / MAM-MD-3680) 販売に関する免責事項
[注射可能薬剤送達の世界市場予測(~2021年)] ( Injectable Drug Delivery Market by Type (Device, Formulation), Therapeutic (Cancer), Usage Pattern (Immunization), Administration (Skin, Musculoskeletal), Distribution Channel (Hospital), Patient Care Setting (Hospital, Home Care) - Forecast to 2021 / MAM-MD-3680) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆